Multiplex plasma profiling of synaptic biomarkers in Alzheimer's disease using NULISA: early alterations, APOE genotype effects, and pTau217 associations
Martinuzzo, C.; Pilotto, A.; Tolassi, C.; Sauer, M.; Benedet, A. L.; Rondina, A.; Galli, A.; Merati, T.; Trasciatti, C.; Girotto, I.; Di Molfetta, G.; Pola, I.; Tan, K.; Traichel, W.; Caratozzolo, S.; Pelucchi, S. C.; Marcello, E.; Gardoni, F.; Di Luca, M.; Zetterberg, H.; Ashton, N. J.; Padovani, A.
Show abstract
INTRODUCTION: Synaptic markers are altered in the CSF of Alzheimer's disease (AD) patients, but their quantification in plasma remains challenging. We evaluated plasma synaptic markers in MCI and mild AD using the nucleic acid linked immunosandwich assay (NULISA) and their correlation with APOE genotype. METHODS: 272 participants (154 CSF confirmed AD, 118 controls) underwent plasma assessment with the NULISA CNS panel. A subset (n=48) also had CSF measurements. Analyses were adjusted for age, sex, comorbidity, and renal function. RESULTS: NULISA revealed plasma alterations in NPTX2, NPTXR, SNAP25, and VSNL1 in AD, with SNAP25 and NPTXR already altered at MCI stage. APOE e4/e4 carriers showed higher plasma SNAP25. Plasma SNAP25 and NPTXR correlated positively with pTau217. No plasma/CSF concordance was observed. DISCUSSION: NULISA identifies plasma synaptic biomarker alterations in early AD, with APOE e4 influencing SNAP25 levels. Associations with pTau217 suggest a link between synaptic damage and tau phosphorylation. Longitudinal studies are warranted.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort 98%
- Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer’s Disease patients and cognitively normal individuals 97%
- Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease 96%
Similar papers in this journal
- Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer’s disease 97%
- CSF sphingomyelins in Alzheimer’s disease, neurodegeneration, and neuroinflammation 96%
- Liver-specific polygenic risk score is more strongly associated than genome-wide score with Alzheimer’s disease diagnosis in a case-control analysis 96%
Similar papers in this journal
- Circular RNA detection identifies circPSEN1 alterations in brain specific to Autosomal Dominant Alzheimer Disease 96%
- TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus 96%
- APOE-ε 4 and BIN1 increase risk of Alzheimer’s disease pathology but not specifically of Lewy body pathology 96%
Similar papers in this journal
- Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer's disease 96%
- Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers 96%
- Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation 95%